Rachel K. King

Alter : 62

Vermögen : 898 165 USD

Größte Unternehmen :

Novavax, Inc. -

GlycoMimetics, Inc.

Übersicht

Rachel K. King founded GlycoMimetics, Inc. Ms. King is President, Chief Executive Officer & Director at Biotechnology Innovation Organization and on the board of 5 other companies.

In her past career she was Principal at Bain & Co., Inc., Executive at NEA Management Co. LLC, Chief Executive Officer of Genetic Therapy, Inc., Executive Vice President of ALZA Corp. and Senior Vice President at Novartis Corp.

Rachel K. King received an undergraduate degree from Dartmouth College and an MBA from Harvard Business School.

Aktuelle Stellungen und Verantwortungsbereiche Rachel K. King

Name	Titel	Seit
Novavax, Inc. (Biotechnologie)	Independent Director	2018
GlycoMimetics, Inc. (Biotechnologie)	Director	2021
Biotechnology Innovation Organization	President, Chief Executive Officer & Director	2022
MdBio, Inc.	Director	-
University of Maryland Biopark	Director	-
Learning Undefeated, Inc.	Director	-

Anteile an Rachel K. King

Name	Aktien	%	Wert
GlycoMimetics, Inc. (GLYC) (Biotechnologie)	653 264	1,02%	816 580 USD
Novavax, Inc. (NVAX) (Biotechnologie)	12 250	0,013%	81 585 USD

Rachel K. King: Persönliches Netzwerk

Name	Verbundene Unternehmen
Daniel M. Junius	GlycoMimetics, Inc. Biotechnology Innovation Organization
Scott E. Koenig	GlycoMimetics, Inc. Biotechnology Innovation Organization
David M. Mott	Novavax, Inc. Biotechnology Innovation Organization
Douglas A. Doerfler	Biotechnology Innovation Organization MdBio, Inc.
Catherine M. Bonuccelli	Biotechnology Innovation Organization
Robert E. Conway	Biotechnology Innovation Organization
James Sapirstein	Biotechnology Innovation Organization
Nick Leschly	Biotechnology Innovation Organization
Jeffrey Peterson	Biotechnology Innovation Organization
Neil Goldsmith	Biotechnology Innovation Organization